Evidence map›Paper›PMID 36347844›Full record

ArticleCell death & disease2022

FMR1 promotes the progression of colorectal cancer cell by stabilizing EGFR mRNA in an m

Yuhan Hu, Qingzu Gao, Shuai Ma, Pei Yu, Shuang Ding, Xiaofei Yao, Zheying Zhang, Shuya Lu, Manman Lu, Jinghang Zhang and 3 more

Open access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Up-regulation of Minibrain/DYRK1A contributes to macrocephaly and brain overgrowth in aProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. mActa pharmaceutica Sinica. B · 2025
    Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Biomolecules · 2025
    Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. FTO-mediated DSP mMolecular cancer · 2024
    Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Yuhan HuDepartment of Pathology, School of Basic Medical Sciences, Xinxiang Medical University, Xinxiang, Henan, 453000, China.
Qingzu GaoDepartment of Pathology, The First Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan, 453000, China.
Shuai MaDepartment of Pathology, School of Basic Medical Sciences, Xinxiang Medical University, Xinxiang, Henan, 453000, China.
Pei YuDepartment of Pathology, School of Basic Medical Sciences, Xinxiang Medical University, Xinxiang, Henan, 453000, China.
Shuang DingDepartment of Pathology, School of Basic Medical Sciences, Xinxiang Medical University, Xinxiang, Henan, 453000, China.
Xiaofei YaoDepartment of Pathology, School of Basic Medical Sciences, Xinxiang Medical University, Xinxiang, Henan, 453000, China.
Zheying ZhangDepartment of Pathology, School of Basic Medical Sciences, Xinxiang Medical University, Xinxiang, Henan, 453000, China.
Shuya LuDepartment of Pathology, School of Basic Medical Sciences, Xinxiang Medical University, Xinxiang, Henan, 453000, China.
Manman LuDepartment of Pathology, School of Basic Medical Sciences, Xinxiang Medical University, Xinxiang, Henan, 453000, China.
Jinghang ZhangDepartment of Pathology, The First Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan, 453000, China.
Yanling WangDepartment of Anesthesiology, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China. wangyl5@mail.sysu.edu.cn.
Xinlai QianDepartment of Pathology, School of Basic Medical Sciences, Xinxiang Medical University, Xinxiang, Henan, 453000, China. qxlsfyblk@126.com.
Jiateng ZhongDepartment of Pathology, School of Basic Medical Sciences, Xinxiang Medical University, Xinxiang, Henan, 453000, China. jtzhong@xxmu.edu.cn.ORCID 0000-0003-0822-2815
Xinxiang Medical University · CNFirst Affiliated Hospital of Xinxiang Medical University · CNSun Yat-sen University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

FMR1, a new m

Indexed as

Colorectal NeoplasmsGene Expression Regulation, NeoplasticCell Line, TumorCell ProliferationErbB ReceptorsFragile X Messenger Ribonucleoprotein 1HumansMethyltransferasesRNA, MessengerEGFR protein, humanErbB ReceptorsFMR1 protein, humanFragile X Messenger Ribonucleoprotein 1MethyltransferasesMETTL3 protein, humanRNA, Messenger

Identifiers

PMID36347844
PMCPMC9643526
OpenAlexW4308524610

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.